Duopharma Biotech Bhd (7148) — Strategic Asset Allocation Index
Duopharma Biotech Bhd (7148) has a Strategic Asset Allocation Index of 73.1% as of December 2025. Strategic assets (PP&E of RM554.08 Million plus long-term investments of RM-) total RM554.08 Million, measured against net assets of RM757.62 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check financial resilience of Duopharma Biotech Bhd to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Duopharma Biotech Bhd Strategic Asset Allocation Index (2016–2024)
This chart shows how Duopharma Biotech Bhd's Strategic Asset Allocation Index has evolved across 9 annual periods from 2016 to 2024. As of December 2025, the index stands at 73.1%, representing strategic assets of RM554.08 Million against net assets of RM757.62 Million MYR. See financial flexibility index of Duopharma Biotech Bhd to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Duopharma Biotech Bhd (2016–2024)
The table below presents the year-by-year Strategic Asset Allocation Index for Duopharma Biotech Bhd from 2016 to 2024, covering 9 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see market value of Duopharma Biotech Bhd.
| Year | SAAI | Strategic Assets (MYR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 80.0% | RM567.52 Million | RM567.52 Million | RM- | RM709.15 Million | ▼ -4.7 pp |
| 2023 | 84.8% | RM582.37 Million | RM582.37 Million | RM- | RM687.12 Million | ▼ -3.8 pp |
| 2022 | 88.5% | RM579.92 Million | RM579.92 Million | RM- | RM655.22 Million | ▲ +1.4 pp |
| 2021 | 87.1% | RM543.44 Million | RM543.44 Million | RM- | RM624.00 Million | ▲ +18.5 pp |
| 2020 | 68.6% | RM441.79 Million | RM441.79 Million | RM- | RM643.82 Million | ▼ -9.2 pp |
| 2019 | 77.8% | RM412.25 Million | RM412.25 Million | RM- | RM529.75 Million | ▼ -2.5 pp |
| 2018 | 80.3% | RM386.18 Million | RM386.18 Million | RM- | RM481.04 Million | ▲ +13.3 pp |
| 2017 | 67.0% | RM321.33 Million | RM321.33 Million | RM- | RM479.87 Million | ▲ +6.2 pp |
| 2016 | 60.8% | RM276.24 Million | RM276.24 Million | RM- | RM454.52 Million | — |